Recombinant factor VIIa treatment for life-threatening haemoptysis

Respirology

Volumn 11, Issue 5, 2006, Pages 652-654

  Yildirim, Huseyin ^a   Ucgun, Irfan ^a   Yalcin, Ahmet Ugur ^a   Gulbaş, Zafer ^a   Şahin, Garip ^a   Acikalin, Mustafa Fuat ^a   Metintas, Muzaffer ^a   Ak, Guntulu ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Diffuse alveolar haemorrhage; Haemoptysis; Pulmonary renal syndrome; Recombinant factor VIIa; Respiratory failure

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; DISEASE SEVERITY; HEMOPHILIA A; HEMOPHILIA B; HEMOPTYSIS; HUMAN; LABORATORY TEST; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL;

ADULT; COAGULANTS; FACTOR VIIA; HEMOPTYSIS; HUMANS; MALE; PULMONARY ALVEOLI; RECOMBINANT PROTEINS;

EID: 33746885078     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00906.x     Document Type: Article

References (13)

1. Betensley AD, Yankaskas JR. Factor VIIa for alveolar hemorrhage in microscopic polyangiitis. Am. J. Respir. Crit. Care Med. 2002; 166: 1291-2.
2. Lynch JP, Leatherman JW. Alveolar hemorrhage syndromes. In: Fishman AP (ed.). Fishman's Pulmonary Disease and Disorders. McGraw-Hill, New York, 1998; 1193-210.
3. Lauque D, Cadranel J, Lazor R et al. Microscopic polyangiitis with alveolar hemorrhage: a study of 29 cases and review of the literature. Medicine (Baltimore) 2000; 79: 222-33.
4. Veldman A, Hoffman M, Ehrenforth S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr. Med. Chem. 2003; 10: 797-811.
5. Hedner U. Dosing with recombinant factor VIIa based on current evidence. Semin. Hematol. 2004; 41 (Suppl. 1): 35-9.
6. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004; 104: 3858-64.
7. Murkin JM. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice. Can. J. Anaesth. 2002; 49: S21-6.
8. Specks U. Diffuse alveolar hemorrhage syndromes. Curr. Opin. Rheumatol. 2001; 13: 12-17.
9. Santos-Ocampo AS, Mandell BF, Fesler BJ. Alveolar hemorrhage in systemic lupus erythematosus. Chest 2000; 118: 1083-90.
10. Pastores SM, Papadopoulos E, Voigt L, Halpern NA. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa. Chest 2003; 124: 2400-3.
11. Ertenli I, Kiraz S, Celik IC et al. Changes in the concentration and distribution of tissue factor pathway inhibitor in Behcet's disease and systemic lupus erythematosus: effect on the prethrombotic state. Ann. Rheum. Dis. 2001; 60: 1149-51.
12. Grounds RM, Bolan C. Clinical experience and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings. Crit. Care 2005; 9 (Suppl. 5): S29-S36.
13. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens, and safety in patient with congenital and acquired factor VIII and IX inhibitors. J. Thromb. Haemost. 2004; 2: 899-909.